{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:24Z","timestamp":1791322284644,"version":"4.3.1"},"reference-count":9,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2008]]},"DOI":"10.4103\/0378-6323.41372","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T05:25:41Z","timestamp":1254288341000},"page":"248","source":"Crossref","is-referenced-by-count":18,"title":["Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema"],"prefix":"10.25259","volume":"74","author":[{"given":"MP","family":"Binitha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.41372-1","first-page":"273","volume-title":"Updated classification of papular mucinosis, lichen myxedematosus and scleromyxedema","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.41372-2","first-page":"561","volume-title":"Scleromyxedema with associated cardiomyopathy","author":"Martins","year":"2004","journal-title":"Anais Brasileiras de Dermatologica"},{"key":"key-10.4103\/0378-6323.41372-3","first-page":"594","volume-title":"Lichen myxedematosus with associated cardiac abnormalities","author":"Morris-Jones","year":"2001","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.41372-4","first-page":"545","volume-title":"Lichen myxedematosus serum stimulating human skin fibroblast proliferation","author":"Harper","year":"1978","journal-title":"Science"},{"key":"key-10.4103\/0378-6323.41372-5","first-page":"37","volume-title":"Scleromyxedema","author":"Dirneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.41372-6","first-page":"41","volume-title":"Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: A retrospective review of Mayo clinic experience","author":"Wetter","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0378-6323.41372-7","first-page":"403","volume-title":"Scleromyxedema: Response to high-dose intravenous immunoglobulin (Hd IVIg)","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.41372-8","doi-asserted-by":"crossref","unstructured":"Prins C, Gelfand EW, French LE. Intravenous immunoglobulin: Properties, mode of action and practical use in dermatology. Acta Dermatol Venereol 2007;87:206-18.","DOI":"10.2340\/00015555-0249"},{"key":"key-10.4103\/0378-6323.41372-9","doi-asserted-by":"crossref","unstructured":"Wojas-Pele A, Blaszczyk M, Glinska M, Jablonska S. Tumorous variant of scleromyxedema. Sucessful therapy with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2005;19:462-5.","DOI":"10.1111\/j.1468-3083.2005.01134.x"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T23:36:24Z","timestamp":1685144184000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijdvl.com\/text.asp?2008\/74\/3\/248\/41372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"alternative-id":["41372"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.41372","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}